Reuters logo
BRIEF-Dova Pharma sees IPO to be priced between $15 and $17/shr
2017年6月19日 / 上午10点28分 / 3 个月前

BRIEF-Dova Pharma sees IPO to be priced between $15 and $17/shr

June 19 (Reuters) - Dova Pharmaceuticals Inc:

* Dova Pharmaceuticals Inc sees IPO of upto 4.06 million shares of common stock to be priced between $15 and $17 per share - SEC filing

* Dova Pharmaceuticals Inc says intends to use about $19.0 million of IPO proceeds to fund commercialization of Avatrombopag

* Dova Pharmaceuticals Inc says intends to use about $21 million of IPO proceeds to fund clinical trials of Avatrombopag for additional indications

* Dova Pharmaceuticals Inc says intends to use about $30 million of IPO proceeds as repayment to EISAI of a portion of our obligations under the EISAI note Source text: (bit.ly/2rHxnhD) Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below